A new COVID-19 variant named ‘Cicada’ is spreading in parts of the US and Europe, but experts say there is no immediate cause for concern in India
A newly identified COVID-19 variant, informally called ‘Cicada’, is spreading across the United States and parts of Europe, raising global attention. However, health experts have clarified that the variant does not currently pose an immediate threat to India.
The variant, scientifically known as BA.3.2, is being monitored by global health bodies including the World Health Organization and the Centers for Disease Control and Prevention. It has shown a rise in infections over the past month, particularly in the US and some Eastern European regions.
Also Read
Despite its spread, experts emphasise that the variant is not linked to more severe illness or large infection waves. In the US, it has been detected in wastewater samples across multiple states and appears to be affecting children more frequently, though without serious health outcomes.
What makes ‘Cicada’ different
The BA.3.2 variant has evolved significantly, with around 75 mutations in its spike protein compared to earlier dominant strains. Experts suggest this could be due to prolonged evolution of the virus in individuals with weakened immune systems.
Despite these mutations, there is no evidence so far that the variant causes more severe disease. It is also not driving major infection waves in affected regions.
Situation in India
Experts in India have stated that there is currently no COVID-19 surge linked to this variant. The country’s population has built strong immune memory through vaccination campaigns and prior infections.
While international travel means the variant could have entered India, it has not yet led to any significant public health concern.
Why severity remains low
Health experts explain that although the virus can still infect individuals, existing immunity helps the body respond quickly, preventing severe illness in most healthy people.
Previous variants such as XFG and LF.7 were responsible for localised cases in India during 2025, but no similar trend is being observed with BA.3.2 at present.
Published: 03 Apr 2026, 08:03 am IST
Related Topics
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.